Generali Investments Towarzystwo Funduszy Inwestycyjnych Procept Bio Robotics Corp Transaction History
Generali Investments Towarzystwo Funduszy Inwestycyjnych
- $157 Billion
- Q1 2025
A detailed history of Generali Investments Towarzystwo Funduszy Inwestycyjnych transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Generali Investments Towarzystwo Funduszy Inwestycyjnych holds 16,000 shares of PRCT stock, worth $910,560. This represents 0.59% of its overall portfolio holdings.
Number of Shares
16,000Holding current value
$910,560% of portfolio
0.59%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
301Shares Held
41.9MCall Options Held
293KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.13MShares$292 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$198 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.14MShares$122 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.42MShares$80.6 Million0.05% of portfolio
-
State Street Corp Boston, MA1.19MShares$67.6 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.54B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...